img

Global Breast Cancer Predictive Genetic Testing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Breast Cancer Predictive Genetic Testing Market Research Report 2024

According to MRAResearch’s new survey, global Breast Cancer Predictive Genetic Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Breast Cancer Predictive Genetic Testing market research.
Key companies engaged in the Breast Cancer Predictive Genetic Testing industry include Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation and NeoGenomics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Breast Cancer Predictive Genetic Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Breast Cancer Predictive Genetic Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Breast Cancer Predictive Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche
Thermo Fisher Scientific
PerkinElmer
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
NeoGenomics
Invitae
Segment by Type
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Breast Cancer Predictive Genetic Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 High Penetrant Genes
1.2.3 Intermediate Penetrant Genes
1.2.4 Low Penetrant Genes
1.3 Market by Application
1.3.1 Global Breast Cancer Predictive Genetic Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Predictive Genetic Testing Market Perspective (2018-2033)
2.2 Breast Cancer Predictive Genetic Testing Growth Trends by Region
2.2.1 Global Breast Cancer Predictive Genetic Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Breast Cancer Predictive Genetic Testing Historic Market Size by Region (2018-2023)
2.2.3 Breast Cancer Predictive Genetic Testing Forecasted Market Size by Region (2024-2033)
2.3 Breast Cancer Predictive Genetic Testing Market Dynamics
2.3.1 Breast Cancer Predictive Genetic Testing Industry Trends
2.3.2 Breast Cancer Predictive Genetic Testing Market Drivers
2.3.3 Breast Cancer Predictive Genetic Testing Market Challenges
2.3.4 Breast Cancer Predictive Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue
3.1.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue (2018-2023)
3.1.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Breast Cancer Predictive Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Predictive Genetic Testing Revenue
3.4 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio
3.4.1 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Predictive Genetic Testing Revenue in 2022
3.5 Breast Cancer Predictive Genetic Testing Key Players Head office and Area Served
3.6 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
3.7 Date of Enter into Breast Cancer Predictive Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Predictive Genetic Testing Breakdown Data by Type
4.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2018-2023)
4.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2024-2033)
5 Breast Cancer Predictive Genetic Testing Breakdown Data by Application
5.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Application (2018-2023)
5.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2018-2033)
6.2 North America Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2023)
6.4 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Cancer Predictive Genetic Testing Market Size (2018-2033)
7.2 Europe Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2023)
7.4 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size (2018-2033)
8.2 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Cancer Predictive Genetic Testing Market Size (2018-2033)
9.2 Latin America Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2023)
9.4 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size (2018-2033)
10.2 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Breast Cancer Predictive Genetic Testing Introduction
11.1.4 Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Introduction
11.3.4 PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.3.5 PerkinElmer Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Introduction
11.4.4 Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.4.5 Quest Diagnostics Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Detail
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Introduction
11.5.4 Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.5.5 Myriad Genetics Recent Development
11.6 Iverson Genetics
11.6.1 Iverson Genetics Company Detail
11.6.2 Iverson Genetics Business Overview
11.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Introduction
11.6.4 Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.6.5 Iverson Genetics Recent Development
11.7 Cancer Genetics
11.7.1 Cancer Genetics Company Detail
11.7.2 Cancer Genetics Business Overview
11.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Introduction
11.7.4 Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.7.5 Cancer Genetics Recent Development
11.8 OncoCyte Corporation
11.8.1 OncoCyte Corporation Company Detail
11.8.2 OncoCyte Corporation Business Overview
11.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Introduction
11.8.4 OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.8.5 OncoCyte Corporation Recent Development
11.9 NeoGenomics
11.9.1 NeoGenomics Company Detail
11.9.2 NeoGenomics Business Overview
11.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Introduction
11.9.4 NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.9.5 NeoGenomics Recent Development
11.10 Invitae
11.10.1 Invitae Company Detail
11.10.2 Invitae Business Overview
11.10.3 Invitae Breast Cancer Predictive Genetic Testing Introduction
11.10.4 Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023)
11.10.5 Invitae Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of High Penetrant Genes
Table 3. Key Players of Intermediate Penetrant Genes
Table 4. Key Players of Low Penetrant Genes
Table 5. Global Breast Cancer Predictive Genetic Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Breast Cancer Predictive Genetic Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Breast Cancer Predictive Genetic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Breast Cancer Predictive Genetic Testing Market Share by Region (2018-2023)
Table 9. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Breast Cancer Predictive Genetic Testing Market Share by Region (2024-2033)
Table 11. Breast Cancer Predictive Genetic Testing Market Trends
Table 12. Breast Cancer Predictive Genetic Testing Market Drivers
Table 13. Breast Cancer Predictive Genetic Testing Market Challenges
Table 14. Breast Cancer Predictive Genetic Testing Market Restraints
Table 15. Global Breast Cancer Predictive Genetic Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Breast Cancer Predictive Genetic Testing Market Share by Players (2018-2023)
Table 17. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2022)
Table 18. Ranking of Global Top Breast Cancer Predictive Genetic Testing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Breast Cancer Predictive Genetic Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
Table 22. Date of Enter into Breast Cancer Predictive Genetic Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Breast Cancer Predictive Genetic Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2018-2023)
Table 26. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2024-2033)
Table 28. Global Breast Cancer Predictive Genetic Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2018-2023)
Table 30. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2024-2033)
Table 32. North America Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Breast Cancer Predictive Genetic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2024-2033) & (US$ Million)
Table 47. Roche Company Detail
Table 48. Roche Business Overview
Table 49. Roche Breast Cancer Predictive Genetic Testing Product
Table 50. Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Product
Table 55. Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. PerkinElmer Company Detail
Table 58. PerkinElmer Business Overview
Table 59. PerkinElmer Breast Cancer Predictive Genetic Testing Product
Table 60. PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 61. PerkinElmer Recent Development
Table 62. Quest Diagnostics Company Detail
Table 63. Quest Diagnostics Business Overview
Table 64. Quest Diagnostics Breast Cancer Predictive Genetic Testing Product
Table 65. Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 66. Quest Diagnostics Recent Development
Table 67. Myriad Genetics Company Detail
Table 68. Myriad Genetics Business Overview
Table 69. Myriad Genetics Breast Cancer Predictive Genetic Testing Product
Table 70. Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 71. Myriad Genetics Recent Development
Table 72. Iverson Genetics Company Detail
Table 73. Iverson Genetics Business Overview
Table 74. Iverson Genetics Breast Cancer Predictive Genetic Testing Product
Table 75. Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 76. Iverson Genetics Recent Development
Table 77. Cancer Genetics Company Detail
Table 78. Cancer Genetics Business Overview
Table 79. Cancer Genetics Breast Cancer Predictive Genetic Testing Product
Table 80. Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 81. Cancer Genetics Recent Development
Table 82. OncoCyte Corporation Company Detail
Table 83. OncoCyte Corporation Business Overview
Table 84. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Product
Table 85. OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 86. OncoCyte Corporation Recent Development
Table 87. NeoGenomics Company Detail
Table 88. NeoGenomics Business Overview
Table 89. NeoGenomics Breast Cancer Predictive Genetic Testing Product
Table 90. NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 91. NeoGenomics Recent Development
Table 92. Invitae Company Detail
Table 93. Invitae Business Overview
Table 94. Invitae Breast Cancer Predictive Genetic Testing Product
Table 95. Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2018-2023) & (US$ Million)
Table 96. Invitae Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Predictive Genetic Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Breast Cancer Predictive Genetic Testing Market Share by Type: 2022 VS 2033
Figure 3. High Penetrant Genes Features
Figure 4. Intermediate Penetrant Genes Features
Figure 5. Low Penetrant Genes Features
Figure 6. Global Breast Cancer Predictive Genetic Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Breast Cancer Predictive Genetic Testing Report Years Considered
Figure 12. Global Breast Cancer Predictive Genetic Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Breast Cancer Predictive Genetic Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Breast Cancer Predictive Genetic Testing Market Share by Region: 2022 VS 2033
Figure 15. Global Breast Cancer Predictive Genetic Testing Market Share by Players in 2022
Figure 16. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Predictive Genetic Testing Revenue in 2022
Figure 18. North America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Breast Cancer Predictive Genetic Testing Market Share by Country (2018-2033)
Figure 20. United States Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Breast Cancer Predictive Genetic Testing Market Share by Country (2018-2033)
Figure 24. Germany Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Share by Region (2018-2033)
Figure 32. China Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Breast Cancer Predictive Genetic Testing Market Share by Country (2018-2033)
Figure 40. Mexico Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Share by Country (2018-2033)
Figure 44. Turkey Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 48. PerkinElmer Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 49. Quest Diagnostics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 50. Myriad Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 51. Iverson Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 52. Cancer Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 53. OncoCyte Corporation Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 54. NeoGenomics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 55. Invitae Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed